OBJECTIVE: To compare two second-generation endometrial ablation systems in @entity1 with @entity1867 ( @entity1867 ) who want conservative surgical treatment. DESIGN: A double-blind, randomized trial. SETTING: A minimal access gynecological surgery unit in northeast England. @entity1 (S): Fifty-seven @entity1 diagnosed with @entity1867 were recruited, with 55 undergoing surgery and completing 12-month follow-up. INTERVENTION(S): Thirty-seven @entity1 underwent a NovaSure endometrial ablation, and 18 had a Cavaterm endometrial ablation. Clinical and quality of life data were collected 6 and 12 months after treatment. MAIN OUTCOME MEASURE(S): @entity2588 , menstrual change, quality of life, sexual activity, @entity1 satisfaction, and procedure acceptability. RESULT(S): @entity2588 , @entity1866 , eumenorrhea, and @entity931 rates for the Cavaterm and Novasure groups at 12 months were 2/18 (11%) vs. 16/37 (43%); 11/18 (61%) vs. 10/37 (27%); 5/18 (27%) vs. 6/37 (16%); and 0/18 vs. 5/37 (13%), respectively. At 12 months, 83% and 92% of @entity1 were either satisfied or very satisfied in the Cavaterm or Novasure groups, respectively. There were no major complications in either group. CONCLUSION(S): Both the Cavaterm and the Novasure endometrial ablation systems are effective in reducing @entity1866 in @entity1 with @entity1867 and achieve high rates of @entity1 satisfaction. The Novasure system achieved a statistically significantly higher rate of @entity2588 in this study.

A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patient', 'PATIENT'] @entity1866 :: ('MESH:D008599', 'Disease') :: ['menstrual loss', 'hypomenorrhea'] @entity1867 :: ('MESH:D008796', 'Disease') :: ['DUB', 'dysfunctional uterine bleeding'] @entity931 :: ('MESH:D008595', 'Disease') :: ['menorrhagia'] @entity2588 :: ('MESH:D000568', 'Disease') :: ['Amenorrhea', 'amenorrhea']
@entity1867 :: (MESH:D008796,Disease) :: ['dysfunctional uterine bleeding']
